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Introduction
A common study design in medical research is to give patients some intervention and then observe what happens to them over time. For example, blood glucose concentrations may be measured several times after a glucose drink. In many cases there may be more than one group of patients, possibly randomised to different treatments. Despite its apparent simplicity the analysis of this form of study presents statistical problems which, judged from published work, are not widely appreciated. The purpose of this paper is to propose a general simple method for a clinically useful and statistically valid analysis. We consider only studies in which each patient receives a single treatment or intervention, so excluding escalating dose studies or crossover trials which require more complicated analysis. Though we also restrict attention to outcome variables that are quantitative because these occur most commonly, the methods can also be applied to ordered data such as pain scores.
Types of time dependency
It is helpful to distinguish two main ways in which the outcome variable may change with time.
Peaked-In many studies the outcome variable starts from a baseline (sometimes zero), rises to a peak, and then returns to baseline. This is displayed as a peaked curve (fig 1) . For example, in a study of post prandial energy expenditure during pregnancy the metabolic rate was measured in women after a 12 hour fast and then at 30 minute intervals for two hours in response to a test meal.' This was done during pregnancy and again once lactation had stopped. The metabolic rate rose to a peak after about 60 minutes and then fell steadily. Women were found to have a reduced energy expenditure during pregnancy. In that study the interest lay in both the total response and the time to reach the maximum value.
Growth-Sometimes the outcome variable steadily increases or decreases with time and does not start to return to its initial value over the period of study. This is displayed as a growth curve (fig 1) . A recent study investigated the role of peripheral vascular tone in hypotension induced by dialysis. (3) Successive observations on a given subject are likely to be correlated-The value at one time point is likely to influence successive time points, so that the significance tests will not be independent. If a test at one point in time gives a significant result, then it is likely that tests performed at points close in time will also give significant results.
The usual approach to the analysis of serial data may thus be criticised on both clinical and statistical grounds. Points (1) and (2) When the outcome measure is the concentration of a substance that has been given-for example, a drug or glucose-the response will often be peaked. The total uptake of the substance may be of interest and can be measured by the area under the response curve in an individual subject. Appendix II gives a method for calculating the area under the curve and shows that it may be interpreted as a type of weighted average of the responses. Thus the area under the response curve may be useful even in cases when a direct interpretation such as the amount of substance absorbed is not possible. An alternative measure of the overall value is the simple mean of the observations. If the intervals between successive observations are the same this will be closely related to the area under the curve. Another feature of peaked data that is frequently of interest is the maximum value, often denoted by Cmax, which may be interpreted as a measure related to the maximum effect of the agent given. The time taken to reach this maximum may also be a clinically important variable. There may be instances where it is the minimum, not the maximum, level that is relevant.
For data in the "growth" category the rate at which the variable is changing over either the whole or part of the experiment is an important feature. A good measure of this rate will often be the slope of a line fitted to the data, which is most easily measured by the regression coefficient estimated by least squares. In some circumstances-for example, after giving different drugs to different groups of subjects-the final outcome, possibly expressed as a difference from baseline, may usefully represent some "achievable" value. This may be more appropriate for data that tend to level off over the last few values-for example, diastolic blood pressure in the treatment of hypertension. Once the appropriate summary measure has been calculated for each subject its values can be treated as raw data for an appropriate statistical analysis. For example, if there are two groups, then means or medians of the summary measures could be compared.
More than one summary measure can be constructed so that different aspects of the response may be investigated. It is not easy to give any general rule about how many measures can be constructed, though clearly each measure should aim at summarising a different aspect of the response. There are seldom more than two or three interesting aspects ofa response curve, and so two or at most three different measures should be enough for a complete analysis of the data. As the principle is to reduce a large number of dependent observations to a smaller number of summaries, the method would be vitiated if too many summaries were used.
The summary measures should have some clear clinical or biological relevance and ideally they should be chosen before the data are collected. This avoids any temptation to choose a particular summary measure because it shows a maximal difference between groups. Indeed, an advantage of the method is that by thinking in terms of relevant summary measures the researcher is compelled to decide on specific questions that the data are required to answer. By thinking in these terms in advance it may be possible to improve the design of a study. For example, ifthe important summary measure is the time to maximum response, then to get a precise estimate frequent measurements would be needed around the time that the maximum response is expected. It would be dogmatic, however, to insist that a summary measure could not be chosen after the data have been examined, especially when the shape of the time-response curve is uncertain.
There are few computer packages that allow computation of summary measures in a routine manner. Nevertheless, studies of this nature are often fairly small, and calculating summary measures by hand or using an ad hoc computer program is quite feasible.
Graphic display
Graphs are an effective way to display data and illustrate conclusions. Nevertheless, it is more difficult to create informative and truthful graphs of repeated measures than might be supposed. The most informative approach and one which is strongly recommended when the data are first analysed is to produce separate graphs of the responses against time for each subject. In order to aid visual comparisons the same axis scaling should be used on all graphs. The plots may be arranged into a panel or grid with separate panels for each group. It may help to order the plots in some way, such as by increasing mean or maximum value. Depending on the sample size it may be feasible to include plots of the raw data in a paper-for example, as was done in the blood glucose example -and we recommend this. If raw data cannot be shown it may be possible to classify the curves and plot representative examples. How the representative examples were chosen (for example, a one in five random sample) should be described in any publication. Fikri and Ghalioungui considered that there were seven classes of curve in their data (fig 3) .'
The question whether the mean of a given set of responses represents a "typical" subject's curve is not simple to answer. The setting in which the mean curve is most likely to be useful occurs when all the peak responses occur at the same time-for example, when subjects all respond quickly to a stimulus.
Summary measures have considerable advantages for plotting because the usual graphical methods, such as histograms, scatter plots, and so on, may be applied to them. Insight may be gained from a scatter plot of any two summary measures. In particular, a useful exercise is to plot the maximum (or minimum) value for each subject against the time that the maximum (or Healthy patients minimum) occurred. This enables large quantities of data to be plotted succinctly and may disclose a relation between the two variables that could not be discerned in the plot of the raw data.
Examples
We illustrate the points discussed above with two examples relating respectively to peaked data and to growth data.
PEAKED DATA We first reconsider the study of aspirin absorption. Figure 4 shows the individual responses in the healthy and ill patients, which clearly belong to the "peaked" category. It is clear that the mean curves in fig 2 concentration. This suggests that the data should be transformed by a logarithmic transformation."' Table I gives the results of an analysis where the summary measures have been log transformed and where the difference between the groups is expressed as the ratio of the geometric means together with the 95% confidence interval." There is strong evidence that there is both a greater peak value and a higher overall level for blood aspirin concentrations in healthy subjects than in ill subjects. Figure 5 gives None of these methods provides results that are as easy to understand as the method of summary measures, nor are they as easy to use. If there are missing values, as is common with this type of study, the method of summary measures will usually still allow the summary to be calculated, but other methods may be difficult to apply. If the times of observations differ among subjects, then all the methods, other than summary measures, will fail. There are problems with all methods of analysis if the data collection period varies greatly among subjects or if data collection is stopped in some subjects for reasons which may relate to the outcome variable. For example, if the time dependence was really peaked but some subjects were withdrawn from the study early while their response was still rising it would seem that the time dependence was one of growth. If a large proportion of subjects do not complete the study, then in common with other types of study this will make sensible analysis of the results very difficult if not impossible.
We have described just two common types of serial data, but other forms of response over time are sometimes of interest. For example, in studies of basal body temperature around the tirne of ovulation the feature of interest is whether there has been a change in the temperature level (and when this occurred). In studies assessing the effectiveness of antihypertensive treatment the outcome of interest may be the level at which the blood pressure stabilises rather than the change from baseline or the rate of change.
One consequence of replacing the measurements on a subject by a single summary measure is that what seemed to be a lot of data suddenly seems rather small. This will be the case when trying to make up for lack of subjects by measuring each subject many times. The strong dependency between measurements close in time on the same patient means that the original wealth of data was to some extent illusory; the summary measures will give a more honest indication of the amount of information that has been collected.
When a researcher is planning a study in which serial measurements on each subject will be collected the intended method of analysis should be considered. It is valuable to have a clear idea of the features of the data that will be of prime interest. The sample size of the study should be taken as the number of subjects, not the total number of observations. If it is known that the timing of a particular feature, such as a peak, is of interest, than extra observations should be made around the time when the feature is likely to occur. For the analysis of such data we recommend the method of summary measures for extracting the useful information from the data. This method is in common use in clinical pharmacology and should become more widespread in all branches of clinical research.
